PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Drug ReportsDesogestrel
Desogestrel
Bekyree, Cyclessa, Desogestrel / Ethinyl Estradiol, Enskyce, Isibloom, Kalliga, Kariva, Pimtrea, Simliya, Velivet, Viorele, Volnea (desogestrel) is a small molecule pharmaceutical. Desogestrel was first approved as Desogen on 1992-12-10. It is used to treat acne vulgaris, endometriosis, and menstruation disturbances in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
urogenital diseasesD000091642
skin and connective tissue diseasesD017437
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
Combinations
Bekyree, Cyclessa, Desogestrel ethinyl estradiol, Enskyce, Isibloom, Kalliga, Kariva, Pimtrea, Simliya, Velivet, Viorele, Volnea (discontinued: Desogen, Desogestrel ethinyl estradiol, Emoquette, Kimidess, Mircette, Ortho-cept)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Desogestrel
+
Ethinyl estradiol
Tradename
Company
Number
Date
Products
CYCLESSAAspen GlobalN-021090 RX2000-12-20
1 products, RLD, RS
Show 3 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
apriANDA2024-06-12
azuretteANDA2024-06-25
bekyreeANDA2023-03-31
caziantANDA2020-12-15
cyred eqANDA2024-12-23
desogestrel and ethinyl estradiolANDA2024-04-22
desogestrel and ethinyl estradiol and ethinyl estradiolANDA2024-04-22
enskyceANDA2024-01-11
isibloomANDA2024-09-25
juleberANDA2024-06-12
Show 9 more
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
prostatic neoplasms—D011471C61
breast neoplasmsEFO_0003869D001943C50
menorrhagiaEFO_0003945D008595N92.0
acne vulgarisEFO_0003894D000152L70
endometriosisEFO_0001065D004715N80
primary ovarian insufficiencyEFO_0004266D016649E28.3
hot flashes—D019584—
hypogonadism—D007006E23.0
menstruation disturbances—D008599N91.5
premature menopause—D008594E28.31
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
G: Genito urinary system and sex hormones
— G03: Sex hormones and modulators of the genital system
— G03A: Hormonal contraceptives for systemic use
— G03AA: Progestogens and estrogen systemic contraceptives, fixed combinations
— G03AA09: Desogestrel and ethinylestradiol
— G03AB: Progestogens and estrogens systemic contraceptives, sequential preparations
— G03AB05: Desogestrel and ethinylestradiol
— G03AC: Progestogen systemic hormonal contraceptives
— G03AC09: Desogestrel
— G03F: Progestogens and estrogens in combination
— G03FB: Progestogens and estrogens, sequential preparations
— G03FB10: Desogestrel and estrogen
HCPCS
No data
Clinical
Clinical Trials
108 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients—————1——1
ContraceptionD003267————1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HemostasisD006487———2———2
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDesogestrel
INNdesogestrel
Description
Desogestrel is a 17beta-hydroxy steroid and a terminal acetylenic compound. It has a role as a contraceptive drug, a progestin and a synthetic oral contraceptive.
Classification
Small molecule
Drug classestrogens; progestins
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
C#C[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3C(=C)C[C@@]21CC
Identifiers
PDB—
CAS-ID54024-22-5
RxCUI—
ChEMBL IDCHEMBL1533
ChEBI ID4453
PubChem CID40973
DrugBankDB00304
UNII ID81K9V7M3A3 (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
Revenue by drug
$
€
£
₣
No data
Estimated US medical usage
Desogestrel
+
Ethinyl estradiol
Total medical expenditures per year (USD, in millions)
Plot placeholder
Mock data
Subscribe for the real data
Number of persons purchased
Plot placeholder
Mock data
Subscribe for the real data
Number of purchases
Plot placeholder
Mock data
Subscribe for the real data
Refill frequency
Plot placeholder
Mock data
Subscribe for the real data
Price per prescription (USD)
Plot placeholder
Mock data
Subscribe for the real data
Tabular view
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,896 documents
View more details
Safety
Black-box Warning
Black-box warning for: Azurette, Bekyree, Cyred eq, Desogestrel and ethinyl estradiol, Enskyce, Isibloom, Juleber, Kalliga, Kariva, Simliya, Viorele
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
3,139 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use